| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Donald J Hayden Jr. last filed a Form 4 in May 2020, as Director at INSM. The filings on record cover 3 companies. From September 2015 to February 2020, the filings on record show 0 open-market purchases and 22 sales. Donald J Hayden Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 62,197 shares of INSM. The INSM filings lean toward selling, a net 106,286 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2017 | RGNX Regenxbio Inc. | Director | Sell | 10,000 | $20.98 | $209,800.00 | -25.9% | |
| Sep 2, 2015 | INSM Insmed Inc | Director | Sell | 25,000 | $24.06 | $601,443.50 | -40.5% |